2020
Adherence to study drug in a stroke prevention trial"?>
Kiran A, Viscoli CM, Furie KL, Gorman M, Kernan WN. Adherence to study drug in a stroke prevention trial"?>. Journal Of Stroke And Cerebrovascular Diseases 2020, 29: 105048. PMID: 32912514, PMCID: PMC7487071, DOI: 10.1016/j.jstrokecerebrovasdis.2020.105048.Peer-Reviewed Original ResearchConceptsRate of discontinuationStudy drugDrug holidayTreatment groupsActive study drugAdverse effectsInsulin Resistance InterventionPremature drug discontinuationRecent ischemic strokeStroke Prevention TrialDouble-blind trialTransient ischemic attackClinical trial researchPhases of adherenceDrug discontinuationIschemic attackStroke preventionDiscontinuation ratesIschemic strokeActive therapyMedical therapyPatient adherencePrevention trialsStroke trialsPharmacodynamic effects
2013
Adherence reporting in randomized controlled trials
Zhang Z, Peluso MJ, Gross CP, Viscoli CM, Kernan WN. Adherence reporting in randomized controlled trials. Clinical Trials 2013, 11: 195-204. PMID: 24357665, DOI: 10.1177/1740774513512565.Peer-Reviewed Original ResearchConceptsAdherence monitoringGeneral medicineStudy drug adherenceReporting of adherenceImportance of adherenceReporting Trials (CONSORT) statementRank correlation coefficientStudy medicationOral pharmacotherapyStudy drugMedian adherencePharmacologic interventionsTreatment acceptanceTreatment adherenceTrials statementTrial characteristicsAdherence reportingLow adherenceStudy qualityTherapeutic effectChi-square analysisConsolidated StandardsRCT manuscriptsAdherence informationAdherence measurement